SCHEMBL493465

SCHEMBL493465

CN(C)C(c1ccccc1)C1CCC(CNC(=O)COC2CCCN(S(=O)(=O)c3c(Cl)cc(Cl)cc3Cl)C2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
RAB9A P51151 1/20 0.36
FAAH O00519 4/20 0.36
ACHE P22303 4/20 0.36
BCHE P06276 3/20 0.36
LMNA P02545 1/20 0.35
EPHX2 P34913 1/20 0.34
ATM Q13315 2/20 0.34
MAPT P10636 3/20 0.34
DPP4 P27487 1/20 0.34
USP2 O75604 2/20 0.34
TP53 P04637 1/20 0.33
THRB P10828 1/20 0.33
PTGIR P43119 1/20 0.33
ACLY P53396 1/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
JAK3 P52333 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493064 0.90 RAB9A (0.39) KMT2AMEN1RAB9ALMNAATM
SCHEMBL493833 0.89 KMT2A (0.43) KMT2AMEN1LMNAATMMAPT
SCHEMBL493203 0.88 FAAH (0.37) KMT2AFAAHACHEBCHELMNA
SCHEMBL492547 0.88 DPP4 (0.45) KMT2AMEN1FAAHACHEBCHE
SCHEMBL493619 0.87 KMT2A (0.37) KMT2AMEN1RAB9AFAAHACHE
SCHEMBL492460 0.87 KMT2A (0.40) KMT2AMEN1RAB9AFAAHACHE
SCHEMBL493218 0.85 HTR6 (0.39) KMT2AMEN1FAAHACHEBCHE
SCHEMBL492613 0.85 KMT2A (0.49) KMT2AMEN1FAAHACHEBCHE
SCHEMBL493757 0.85 KMT2A (0.39) KMT2AMEN1RAB9ALMNAEPHX2
SCHEMBL492870 0.84 FAAH (0.38) KMT2AMEN1FAAHACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD KMT2A 1749/4885MEN1 4132/4885RAB9A 2004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.